波动有点大！ 今日，在港股市场上，药捷安康-B（02617.HK）的股价剧烈波动。该股早盘涨幅一度超过60%，最高触及679.5港元/股， 市值一度逼近2700亿港元。 然而，今日午间，药捷安康突然公告称，不知悉股价及成交量异动原因，集团的业务营运及财务状况并无重大变动。午 后，药捷安康的股价急速跳水，跌幅一度超过60%，最低触及165港元/股，市值跌至不到700亿港元，全天振幅超过 120%。 药捷安康称，上述试验旨在评估替恩戈替尼片联合氟维司群注射液在经治失败的HR+/HER2-复发或转移性乳腺癌患者中 的安全性、疗效及药代动力学的开放标签、多中心、Ⅱ期临床研究。早期临床研究结果表明，替恩戈替尼单药在经历过 多种治疗的HR+/HER2-乳腺癌患者中显示出令人鼓舞的临床效果，且与氟维司群的联合用药具有药理学协同作用，可能 为此类患者的治疗带来新的突破。 药捷安康股价大跌 今日早盘，药捷安康大幅拉升，股价最高触及679.5港元，市值一度逼近2700亿港元。然而，午后"风云突变"，14时10分 过后，卖单持续涌现，导致公司股价持续跳水，最低触及165港元/股，跌幅一度高达60.24%。截至收盘时，药捷安康股 价 ...

Group 1 - A-share market experienced a significant rally, with the ChiNext Index surpassing 3000 points for the first time in over three years, and the Sci-Tech 50 Index seeing an intraday increase of over 5% [2][4] - Key stocks in the Sci-Tech board, such as Haiguang Information and Cambricon Technologies, saw substantial gains, with Haiguang Information hitting a historical high of 220.84 yuan and a market capitalization exceeding 510 billion yuan [4][5] - The ChiNext Index recorded a rise of 4.31%, reaching 3029.58 points, with a total trading volume of approximately 419.48 billion yuan [5] Group 2 - The Hong Kong stock market showed a slight decline in the morning, with notable stocks like Semiconductor Manufacturing International Corporation and China Hongqiao Group performing well, while others like CSPC Pharmaceutical Group faced losses [6] - In the Hong Kong market, Longi Green Energy and other stocks saw significant intraday increases, with Longi Green Energy rising over 19% [6] - The announcement of clinical trial results for Tinengotinib by Yaojie Ankang-B indicated promising outcomes for breast cancer treatment, contributing to the stock's strong performance [7]